Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

  1. Garcia-Donas, J.
  2. Martínez-Urbistondo, D.
  3. Velázquez Kennedy, K.
  4. Villares, P.
  5. Barquin, A.
  6. Dominguez, A.
  7. Rodriguez-Moreno, J.F.
  8. Caro, E.
  9. Suarez del Villar, R.
  10. Nistal-Villan, E.
  11. Yagüe, M.
  12. Ortiz, M.
  13. Barba, M.
  14. Ruiz-Llorente, S.
  15. Quiralte, M.
  16. Zanin, M.
  17. Rodríguez, C.
  18. Navarro, P.
  19. Berraondo, P.
  20. Madurga, R.
Journal:
Frontiers in Immunology

ISSN: 1664-3224

Year of publication: 2023

Volume: 14

Type: Article

DOI: 10.3389/FIMMU.2023.1156603 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals